|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 526.24 USD | +0.08% |
|
-1.41% | -6.87% |
| Capitalization | 186B 159B 147B 137B 256B 17,125B 271B 1,679B 667B 8,086B 699B 685B 29,413B | P/E ratio 2025 |
72x | P/E ratio 2026 * | 58.3x |
|---|---|---|---|---|---|
| Enterprise value | 181B 154B 143B 134B 249B 16,665B 264B 1,634B 649B 7,868B 680B 666B 28,622B | EV / Sales 2025 |
19.9x | EV / Sales 2026 * | 15.5x |
| Free-Float |
99.33% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Intuitive Surgical, Inc.
| 1 day | +0.11% | ||
| 1 week | -1.41% | ||
| Current month | -6.87% | ||
| 1 month | -8.64% | ||
| 3 months | -4.33% | ||
| 6 months | +5.08% | ||
| Current year | -6.87% |
| 1 week | 518.64 |  | 540 |
| 1 month | 518.64 | | 603.88 |
| Current year | 518.64 | | 603.88 |
| 1 year | 425 | | 609.08 |
| 3 years | 222.65 | | 616 |
| 5 years | 180.07 | | 616 |
| 10 years | 55.78 | | 616 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dave Rosa Rosa
CEO | Chief Executive Officer | 58 | 01/07/2025 |
Jamie Samath
DFI | Director of Finance/CFO | 55 | 01/01/2022 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gary Guthart
CHM | Chairman | 60 | 01/07/2025 |
Mark Rubash
BRD | Director/Board Member | 68 | 19/10/2007 |
Dave Rosa Rosa
BRD | Director/Board Member | 58 | 24/07/2024 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +0.75% | 3.76% | 26 M€ | |
| +4.04% | 1.86% | 147 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.08% | -1.41% | -13.35% | +106.04% | 186B | |
| -1.66% | +1.82% | +9.59% | +4.16% | 240B | |
| -2.12% | -0.06% | -4.00% | -14.86% | 170B | |
| +0.77% | +4.58% | -9.39% | +100.87% | 135B | |
| -1.84% | -6.48% | -20.32% | -11.63% | 57.83B | |
| -1.05% | -0.57% | +21.67% | +4.76% | 49B | |
| -2.55% | -2.91% | -11.07% | -14.76% | 39.3B | |
| -1.44% | -2.11% | +1.32% | +6.61% | 37.19B | |
| -1.85% | -1.25% | -8.43% | +16.12% | 37.3B | |
| +1.04% | -4.20% | -14.76% | -42.67% | 33.56B | |
| Average | -1.06% | -1.42% | -4.87% | +15.46% | 98.58B | |
| Weighted average by Cap. | -1.00% | -0.46% | -3.49% | +30.73% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 9.96B 8.47B 7.85B 7.33B 13.67B 915B 14.49B 89.69B 35.61B 432B 37.33B 36.57B 1,571B | 11.46B 9.75B 9.03B 8.44B 15.74B 1,053B 16.68B 103B 40.99B 497B 42.97B 42.09B 1,808B |
| Net income | 2.73B 2.32B 2.15B 2.01B 3.75B 251B 3.97B 24.59B 9.76B 118B 10.23B 10.02B 431B | 3.17B 2.69B 2.5B 2.33B 4.35B 291B 4.61B 28.55B 11.33B 137B 11.88B 11.64B 500B |
| Net Debt | -5.01B -4.26B -3.95B -3.69B -6.89B -461B -7.3B -45.18B -17.93B -218B -18.8B -18.42B -791B | -9.19B -7.81B -7.24B -6.77B -12.62B -844B -13.37B -82.76B -32.86B -398B -34.44B -33.74B -1,449B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/01/26 | 528.31 $ | +0.48% | 1,187,324 |
| 22/01/26 | 525.81 $ | +0.40% | 2,911,761 |
| 21/01/26 | 523.69 $ | -0.71% | 2,033,885 |
| 20/01/26 | 527.44 $ | -1.41% | 2,149,740 |
| 16/01/26 | 535.00 $ | -1.17% | 3,015,488 |
Delayed Quote Nasdaq, January 23, 2026 at 09:03 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ISRG Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition